Souliotis, Kyriakos - 2016
Background While there is currently no cure for multiple sclerosis (MS), treatment with biologic disease modifying drugs (bDMDs) can reduce the impact of the condition on the lives of patients. In Greece, the regulatory change in the distribution system of bDMDs, limited their administration...